Ignite Creation Date:
2025-12-24 @ 12:47 PM
Ignite Modification Date:
2026-01-04 @ 3:41 AM
Study NCT ID:
NCT02234661
Status:
COMPLETED
Last Update Posted:
2021-03-01
First Post:
2014-08-07
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Expanding the Cycle of Opportunity: Simultaneously Educating Parents and Children in Head Start
Sponsor:
Northwestern University
Organization:
Study Overview
Official Title:
Expanding the Cycle of Opportunity: Simultaneously Educating Parents and Children in Head Start
Status:
COMPLETED
Status Verified Date:
2021-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
CAPFAST
Brief Summary:
The CAP Family Advancement Study (CAP FAST) is a randomized control trial of CareerAdvance®, a dual-generation program providing education, career coaching, and soft-skills training for parents while their children attend CAP Tulsa's Head Start programs.
Detailed Description:
Randomization will take place with all applicants who have agreed to the study and are selected to participate in CareerAdvance®. Two-thirds of participants will be selected for the treatment group and will be able to enroll in CareerAdvance® immediately. The other one-third of the participants will be assigned to the control group and will not be able to enroll in CareerAdvance® for two years. Those who are selected for the control group will have access to CAP Tulsa's rich array of service outside of CareerAdvance®, including high quality early childhood education. The randomization process is introduced to parents during CareerAdvance® information sessions, and consent for the randomization process is required in order to apply to CareerAdvance®.
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: